<p>DENTSPLY SIRONA（纳斯达克代码：XRAY - 获取免费报告）在周五发布的一份报告中，Stifel Nicolaus 的股票研究分析师将其目标价格从 19.00 美元下调至 17.00 美元，Benzinga 报道。该券商目前对这家医疗器械供应商的股票给予 “持有” 评级。Stifel Nicolaus 的目标价格暗示该股票当前价格有 33.39% 的潜在上涨空间。</p>
<ul>
<li>Dentsply 股票正在重新定价</li>
</ul>
<p>其他几位分析师最近也对该股票发表了看法。Piper Sandler 在 4 月 30 日的研究报告中将 DENTSPLY SIRONA 的目标价格从 20.00 美元下调至 16.00 美元，并对该公司给予 “中性” 评级。华尔街 Zen 在 7 月 13 日的研究报告中将 DENTSPLY SIRONA 的评级从 “持有” 上调至 “买入”。摩根士丹利在 4 月 15 日的研究报告中将 DENTSPLY SIRONA 的评级从 “增持” 下调至 “持平”，并为该公司设定了 14.00 美元的目标价格。Needham &amp; Company LLC 在 7 月 21 日的研究报告中重申了对 DENTSPLY SIRONA 的 “持有” 评级。最后，Barrington Research 在 7 月 22 日的研究报告中重申了 “跑赢大盘” 的评级，并为 DENTSPLY SIRONA 设定了 21.00 美元的目标价格。共有 11 位投资分析师对该股票给予 “持有” 评级，3 位分析师给予 “买入” 评级。根据 MarketBeat 的数据，DENTSPLY SIRONA 目前的共识评级为 “持有”，平均目标价格为 19.36 美元。</p>
<p>获取 <strong>DENTSPLY SIRONA</strong> 的提醒：</p>
<p><strong>阅读我们对 DENTSPLY SIRONA 的最新分析</strong></p>
<h2>DENTSPLY SIRONA 价格表现</h2>
<p>在周五的午盘交易中，纳斯达克 XRAY 的股票下跌 0.49 美元，报 12.75 美元。该公司交易了 847,438 股，低于其平均交易量 2,931,700 股。DENTSPLY SIRONA 的 52 周低点为 12.16 美元，52 周高点为 27.48 美元。该公司的速动比率为 0.76，流动比率为 1.10，债务与股本比率为 0.79。该股票的市值为 25.4 亿美元，市盈率为-2.81，市盈增长比率为 0.97，贝塔值为 0.94。该公司的 50 日移动平均价格为 15.77 美元，200 日移动平均价格为 15.96 美元。</p>
<p>DENTSPLY SIRONA（纳斯达克代码：XRAY - 获取免费报告）最近一次发布季度财报是在 8 月 7 日。该医疗器械供应商报告本季度每股收益（EPS）为 0.52 美元，超出分析师共识预期的 0.50 美元，超出幅度为 0.02 美元。该公司本季度的收入为 9.36 亿美元，而共识预期为 9.2967 亿美元。DENTSPLY SIRONA 的净利润率为-24.42%，股本回报率为 14.31%。与去年同期相比，该公司的收入下降了 4.9%。在去年同期，该公司每股收益为 0.49 美元。卖方分析师预测，DENTSPLY SIRONA 在当前财政年度将发布 1.84 美元的每股收益。</p>
<h2>DENTSPLY SIRONA 的机构交易</h2>
<p>几家大型投资者最近买入和卖出了该公司的股票。Colonial Trust Co SC 在第四季度购买了 DENTSPLY SIRONA 的新头寸，价值约 26,000 美元。Mirae Asset Global Investments Co. Ltd.在第一季度购买了 DENTSPLY SIRONA 的新股份，价值 25,000 美元。Trust Co. of Toledo NA OH 在第二季度购买了 DENTSPLY SIRONA 的新头寸，价值 27,000 美元。Parkside Financial Bank &amp; Trust 在第二季度将其在 DENTSPLY SIRONA 的持股增加了 620.6%。Parkside Financial Bank &amp; Trust 目前拥有 1,715 股该医疗器械供应商的股票，价值 27,000 美元，此前在该期间内又购买了 1,477 股。最后，Brooklyn Investment Group 在第一季度购买了 DENTSPLY SIRONA 的新头寸，价值 26,000 美元。95.70% 的股票由机构投资者持有。</p>
<h2>DENTSPLY SIRONA 公司简介</h2>
<p>（获取免费报告）</p>
<p>DENTSPLY SIRONA Inc 在全球范围内制造和销售各种牙科产品和技术。它分为四个部门：连接技术解决方案、基本牙科解决方案、正畸和植入解决方案，以及 Wellspect Healthcare。该公司提供的牙科设备包括成像设备、电动牙科手持器、治疗中心、其他仪器、汞合金机、混合机和瓷炉；以及支持牙科修复的牙科 CAD/CAM 技术，如口内扫描仪、3D 打印机、铣床、其他软件和服务，以及全椅旁经济型美学陶瓷牙科修复的 DS Core 云平台。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票比 DENTSPLY SIRONA 更好</li>
<li>如何投资科技股及值得考虑的顶级科技股</li>
<li>为什么 Axon 的 16% 激增标志着公共安全技术的新纪元</li>
<li>股票回购是什么？投资者的全面指南</li>
<li>DraftKings 发布创纪录季度，瞄准盈利</li>
<li>为什么除息日对投资者重要？</li>
<li>亚马逊在 IonQ 中获得股权——有潜在上涨空间吗？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9WFJBWQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9WFJBWQ"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审查。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 DENTSPLY SIRONA 吗？</h2>
<p>在你考虑 DENTSPLY SIRONA 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前进行购买……而 DENTSPLY SIRONA 并不在名单上。</p>
<p>虽然登士柏西诺德目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

登士柏西诺德

<p>Stifel Nicolaus 将 DENTSPLY SIRONA (NASDAQ:XRAY) 的目标股价从 19.00 美元下调至 17.00 美元，维持 “持有” 评级。这表明从当前股价来看，潜在上涨空间为 33.39%。其他分析师也调整了他们的评级，Piper Sandler 设定的目标为 16.00 美元，摩根士丹利为 14.00 美元。DENTSPLY SIRONA 的股票目前交易价格为 12.75 美元，52 周范围为 12.16 美元至 27.48 美元。该公司报告每股收益为 0.52 美元，超出预期，但收入同比下降了 4.9%</p>

<p>DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) had its target price reduced by equities research analysts at Stifel Nicolaus from $19.00 to $17.00 in a report released on Friday,Benzinga reports. The brokerage presently has a &#34;hold&#34; rating on the medical instruments supplier's stock. Stifel Nicolaus' target price would suggest a potential upside of 33.39% from the stock's current price.</p>
<div class="lb-trans"><p>DENTSPLY SIRONA（纳斯达克代码：XRAY - 获取免费报告）在周五发布的一份报告中，Stifel Nicolaus 的股票研究分析师将其目标价格从 19.00 美元下调至 17.00 美元，Benzinga 报道。该券商目前对这家医疗器械供应商的股票给予 “持有” 评级。Stifel Nicolaus 的目标价格暗示该股票当前价格有 33.39% 的潜在上涨空间。</p>
</div><ul>
<li>Dentsply Stock is Repricing Itself</li>
</ul>
<div class="lb-trans"><ul>
<li>Dentsply 股票正在重新定价</li>
</ul>
</div><p>Several other analysts also recently weighed in on the stock. Piper Sandler lowered their price target on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a &#34;neutral&#34; rating for the company in a research note on Wednesday, April 30th. Wall Street Zen raised shares of DENTSPLY SIRONA from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note on Sunday, July 13th. Morgan Stanley downgraded shares of DENTSPLY SIRONA from an &#34;overweight&#34; rating to an &#34;equal weight&#34; rating and set a $14.00 price target for the company. in a research note on Tuesday, April 15th. Needham &amp; Company LLC reissued a &#34;hold&#34; rating on shares of DENTSPLY SIRONA in a research note on Monday, July 21st. Finally, Barrington Research reissued an &#34;outperform&#34; rating and issued a $21.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, July 22nd. Eleven investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, DENTSPLY SIRONA currently has a consensus rating of &#34;Hold&#34; and an average price target of $19.36.</p>
<div class="lb-trans"><p>其他几位分析师最近也对该股票发表了看法。Piper Sandler 在 4 月 30 日的研究报告中将 DENTSPLY SIRONA 的目标价格从 20.00 美元下调至 16.00 美元，并对该公司给予 “中性” 评级。华尔街 Zen 在 7 月 13 日的研究报告中将 DENTSPLY SIRONA 的评级从 “持有” 上调至 “买入”。摩根士丹利在 4 月 15 日的研究报告中将 DENTSPLY SIRONA 的评级从 “增持” 下调至 “持平”，并为该公司设定了 14.00 美元的目标价格。Needham &amp; Company LLC 在 7 月 21 日的研究报告中重申了对 DENTSPLY SIRONA 的 “持有” 评级。最后，Barrington Research 在 7 月 22 日的研究报告中重申了 “跑赢大盘” 的评级，并为 DENTSPLY SIRONA 设定了 21.00 美元的目标价格。共有 11 位投资分析师对该股票给予 “持有” 评级，3 位分析师给予 “买入” 评级。根据 MarketBeat 的数据，DENTSPLY SIRONA 目前的共识评级为 “持有”，平均目标价格为 19.36 美元。</p>
</div><p>Get <strong>DENTSPLY SIRONA</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>DENTSPLY SIRONA</strong> 的提醒：</p>
</div><p><strong>Read Our Latest Analysis on DENTSPLY SIRONA</strong></p>
<div class="lb-trans"><p><strong>阅读我们对 DENTSPLY SIRONA 的最新分析</strong></p>
</div><h2>DENTSPLY SIRONA Price Performance</h2>
<div class="lb-trans"><h2>DENTSPLY SIRONA 价格表现</h2>
</div><p>Shares of NASDAQ XRAY traded down $0.49 during mid-day trading on Friday, reaching $12.75. 847,438 shares of the company were exchanged, compared to its average volume of 2,931,700. DENTSPLY SIRONA has a 52 week low of $12.16 and a 52 week high of $27.48. The company has a quick ratio of 0.76, a current ratio of 1.10 and a debt-to-equity ratio of 0.79. The stock has a market capitalization of $2.54 billion, a PE ratio of -2.81, a PEG ratio of 0.97 and a beta of 0.94. The company's 50 day moving average price is $15.77 and its 200 day moving average price is $15.96.</p>
<div class="lb-trans"><p>在周五的午盘交易中，纳斯达克 XRAY 的股票下跌 0.49 美元，报 12.75 美元。该公司交易了 847,438 股，低于其平均交易量 2,931,700 股。DENTSPLY SIRONA 的 52 周低点为 12.16 美元，52 周高点为 27.48 美元。该公司的速动比率为 0.76，流动比率为 1.10，债务与股本比率为 0.79。该股票的市值为 25.4 亿美元，市盈率为-2.81，市盈增长比率为 0.97，贝塔值为 0.94。该公司的 50 日移动平均价格为 15.77 美元，200 日移动平均价格为 15.96 美元。</p>
</div><p>DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.50 by $0.02. The company had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The firm's revenue was down 4.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.49 EPS. Sell-side analysts forecast that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>DENTSPLY SIRONA（纳斯达克代码：XRAY - 获取免费报告）最近一次发布季度财报是在 8 月 7 日。该医疗器械供应商报告本季度每股收益（EPS）为 0.52 美元，超出分析师共识预期的 0.50 美元，超出幅度为 0.02 美元。该公司本季度的收入为 9.36 亿美元，而共识预期为 9.2967 亿美元。DENTSPLY SIRONA 的净利润率为-24.42%，股本回报率为 14.31%。与去年同期相比，该公司的收入下降了 4.9%。在去年同期，该公司每股收益为 0.49 美元。卖方分析师预测，DENTSPLY SIRONA 在当前财政年度将发布 1.84 美元的每股收益。</p>
</div><h2>Institutional Trading of DENTSPLY SIRONA</h2>
<div class="lb-trans"><h2>DENTSPLY SIRONA 的机构交易</h2>
</div><p>Several large investors have recently bought and sold shares of the company. Colonial Trust Co SC purchased a new position in DENTSPLY SIRONA in the 4th quarter worth approximately $26,000. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of DENTSPLY SIRONA during the 1st quarter valued at $25,000. Trust Co. of Toledo NA OH bought a new position in DENTSPLY SIRONA in the 2nd quarter worth $27,000. Parkside Financial Bank &amp; Trust boosted its holdings in DENTSPLY SIRONA by 620.6% in the 2nd quarter. Parkside Financial Bank &amp; Trust now owns 1,715 shares of the medical instruments supplier's stock worth $27,000 after buying an additional 1,477 shares during the period. Finally, Brooklyn Investment Group bought a new position in DENTSPLY SIRONA in the 1st quarter worth $26,000. 95.70% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>几家大型投资者最近买入和卖出了该公司的股票。Colonial Trust Co SC 在第四季度购买了 DENTSPLY SIRONA 的新头寸，价值约 26,000 美元。Mirae Asset Global Investments Co. Ltd.在第一季度购买了 DENTSPLY SIRONA 的新股份，价值 25,000 美元。Trust Co. of Toledo NA OH 在第二季度购买了 DENTSPLY SIRONA 的新头寸，价值 27,000 美元。Parkside Financial Bank &amp; Trust 在第二季度将其在 DENTSPLY SIRONA 的持股增加了 620.6%。Parkside Financial Bank &amp; Trust 目前拥有 1,715 股该医疗器械供应商的股票，价值 27,000 美元，此前在该期间内又购买了 1,477 股。最后，Brooklyn Investment Group 在第一季度购买了 DENTSPLY SIRONA 的新头寸，价值 26,000 美元。95.70% 的股票由机构投资者持有。</p>
</div><h2>DENTSPLY SIRONA Company Profile</h2>
<div class="lb-trans"><h2>DENTSPLY SIRONA 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.</p>
<div class="lb-trans"><p>DENTSPLY SIRONA Inc 在全球范围内制造和销售各种牙科产品和技术。它分为四个部门：连接技术解决方案、基本牙科解决方案、正畸和植入解决方案，以及 Wellspect Healthcare。该公司提供的牙科设备包括成像设备、电动牙科手持器、治疗中心、其他仪器、汞合金机、混合机和瓷炉；以及支持牙科修复的牙科 CAD/CAM 技术，如口内扫描仪、3D 打印机、铣床、其他软件和服务，以及全椅旁经济型美学陶瓷牙科修复的 DS Core 云平台。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than DENTSPLY SIRONA</li>
<li>How to Invest in Tech Stocks and Top Tech Stocks to Consider</li>
<li>Why Axon's 16% Surge Signals a New Era in Public Safety Tech</li>
<li>What is a buyback in stocks? A comprehensive guide for investors</li>
<li>DraftKings Posts Record Quarter, Eyes Profitability</li>
<li>Why is the Ex-Dividend Date Significant to Investors?</li>
<li>Amazon Takes an Equity Stake in IonQ—Any Upside Potential?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 DENTSPLY SIRONA 更好</li>
<li>如何投资科技股及值得考虑的顶级科技股</li>
<li>为什么 Axon 的 16% 激增标志着公共安全技术的新纪元</li>
<li>股票回购是什么？投资者的全面指南</li>
<li>DraftKings 发布创纪录季度，瞄准盈利</li>
<li>为什么除息日对投资者重要？</li>
<li>亚马逊在 IonQ 中获得股权——有潜在上涨空间吗？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9WFJBWQ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=XRAY"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审查。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in DENTSPLY SIRONA Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 DENTSPLY SIRONA 吗？</h2>
</div><p>Before you consider DENTSPLY SIRONA, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 DENTSPLY SIRONA 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前进行购买……而 DENTSPLY SIRONA 并不在名单上。</p>
</div><p>While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然登士柏西诺德目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Stifel Nicolaus 将登士柏西诺德（NASDAQ:XRAY）的目标股价下调至 17.00 美元